• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于诊断人类神经囊尾蚴病的特异性抗原检测酶联免疫吸附测定法。秘鲁囊尾蚴病工作组。

A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru.

作者信息

Garcia H H, Harrison L J, Parkhouse R M, Montenegro T, Martinez S M, Tsang V C, Gilman R H

机构信息

Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru.

出版信息

Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):411-4. doi: 10.1016/s0035-9203(98)91069-0.

DOI:10.1016/s0035-9203(98)91069-0
PMID:9850394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3025427/
Abstract

An enzyme-linked immunosorbent assay (ELISA) for the detection of antigen secreted by viable Taenia solium metacestodes (Ag-ELISA) was applied to 43 pre-treatment and 47 follow-up cerebrospinal fluid (CSF) samples from Peruvian patients with neurocysticercosis demonstrated by computed tomography and enzyme-linked immunoelectrotransfer blot assay. The sensitivity of the assay was 86%. Negative pre-treatment results in the Ag-ELISA test were restricted to patients with only a single live cyst or only enhancing lesions. Patients with hydrocephalus had higher levels of circulating antigen. There was no difference between antigen levels in CSF taken before and immediately after treatment (day 14). Levels of parasite antigen were significantly positively correlated with the number of live cysts detected by tomography and were also proportional to the number and intensity of antibody reactions recognized by the immunoblot diagnostic test. In contrast, there was a negative correlation with the number of enhancing lesions revealed by tomography, supporting the hypothesis that enhancing lesions correspond to a terminal, moribund stage of the parasite. The use of antigen-detection tests specific for viable metacestodes has immediate utility in the clinical context, not only providing important information on the viability of the parasites but also leading to an improved understanding of the pathogenesis of neurocysticercosis before and after drug treatment.

摘要

一种用于检测猪带绦虫活囊尾蚴分泌抗原的酶联免疫吸附试验(Ag-ELISA),应用于43份治疗前和47份随访时的脑脊液(CSF)样本,这些样本来自经计算机断层扫描和酶联免疫电转移印迹试验证实患有神经囊尾蚴病的秘鲁患者。该试验的敏感性为86%。Ag-ELISA试验治疗前的阴性结果仅限于仅有单个活囊或仅有强化病灶的患者。脑积水患者循环抗原水平较高。治疗前和治疗后第14天立即采集的脑脊液中的抗原水平无差异。寄生虫抗原水平与断层扫描检测到的活囊数量显著正相关,也与免疫印迹诊断试验识别的抗体反应数量和强度成正比。相比之下,与断层扫描显示的强化病灶数量呈负相关,支持强化病灶对应于寄生虫终末期、濒死期的假说。使用针对活囊尾蚴的抗原检测试验在临床环境中具有直接用途,不仅提供有关寄生虫活力的重要信息,还能增进对药物治疗前后神经囊尾蚴病发病机制的理解。

相似文献

1
A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru.一种用于诊断人类神经囊尾蚴病的特异性抗原检测酶联免疫吸附测定法。秘鲁囊尾蚴病工作组。
Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):411-4. doi: 10.1016/s0035-9203(98)91069-0.
2
Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA.
Parasite. 2003 Mar;10(1):65-8. doi: 10.1051/parasite/2003101p65.
3
Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients.
Trans R Soc Trop Med Hyg. 2000 Nov-Dec;94(6):673-6. doi: 10.1016/s0035-9203(00)90228-1.
4
Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only.血清寄生虫抗原仅可预测有明显钙化囊虫病患者脑内活寄生虫的存在。
Clin Infect Dis. 2013 Oct;57(7):e154-9. doi: 10.1093/cid/cit422. Epub 2013 Jun 20.
5
Saline extract of Taenia saginata metacestodes as an alternative antigen for the immunodiagnosis of neurocysticercosis in human cerebrospinal fluid.牛带绦虫囊尾蚴盐水提取物作为人类脑脊液中神经囊尾蚴病免疫诊断的替代抗原。
Parasitol Res. 2009 Jul;105(1):169-74. doi: 10.1007/s00436-009-1379-z. Epub 2009 Feb 27.
6
Urine antigen detection for the diagnosis of human neurocysticercosis.尿液抗原检测用于诊断人类神经囊尾蚴病。
Am J Trop Med Hyg. 2009 Mar;80(3):379-83.
7
Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis.
Am J Trop Med Hyg. 2002 Apr;66(4):427-30. doi: 10.4269/ajtmh.2002.66.427.
8
Antigenic fractions from Taenia crassiceps metacestodes obtained by hydrophobicity for the immunodiagnosis of active and inactive forms of neurocysticercosis in human cerebrospinal fluid samples.通过疏水性从肥胖带绦虫囊尾蚴中获得的抗原组分,用于人类脑脊液样本中活动性和非活动性神经囊尾蚴病的免疫诊断。
Parasitol Int. 2017 Apr;66(2):134-138. doi: 10.1016/j.parint.2016.12.009. Epub 2016 Dec 21.
9
Comparison of T24H-his, GST-T24H and GST-Ts8B2 recombinant antigens in western blot, ELISA and multiplex bead-based assay for diagnosis of neurocysticercosis.T24H-his、GST-T24H和GST-Ts8B2重组抗原在蛋白质免疫印迹法、酶联免疫吸附测定法和基于多重微珠的检测法中用于神经囊尾蚴病诊断的比较
Parasit Vectors. 2017 May 15;10(1):237. doi: 10.1186/s13071-017-2160-2.
10
Concordance between two monoclonal antibody-based antigen detection enzyme-linked immunosorbent assays for measuring cysticercal antigen levels in sera from pigs experimentally infected with Taenia solium and Taenia hydatigena.两种基于单克隆抗体的抗原检测酶联免疫吸附试验在检测实验感染猪囊尾蚴和细粒棘球蚴的血清中囊虫抗原水平的一致性。
Parasit Vectors. 2024 Apr 2;17(1):172. doi: 10.1186/s13071-024-06197-6.

引用本文的文献

1
The performance of a point-of-care test for the diagnosis of Neurocysticercosis in a resource-poor community setting in Zambia - a diagnostic accuracy study.赞比亚资源匮乏社区环境中用于诊断神经囊尾蚴病的即时检测性能——一项诊断准确性研究
EClinicalMedicine. 2024 Nov 2;77:102893. doi: 10.1016/j.eclinm.2024.102893. eCollection 2024 Nov.
2
Concordance between two monoclonal antibody-based antigen detection enzyme-linked immunosorbent assays for measuring cysticercal antigen levels in sera from pigs experimentally infected with Taenia solium and Taenia hydatigena.两种基于单克隆抗体的抗原检测酶联免疫吸附试验在检测实验感染猪囊尾蚴和细粒棘球蚴的血清中囊虫抗原水平的一致性。
Parasit Vectors. 2024 Apr 2;17(1):172. doi: 10.1186/s13071-024-06197-6.
3
Demographics and Clinical Characteristics of Patients with Neurocysticercosis: A Retrospective Study from Dali, China.神经囊尾蚴病患者的人口统计学和临床特征:来自中国大理的一项回顾性研究
Saudi J Med Med Sci. 2023 Oct-Dec;11(4):283-291. doi: 10.4103/sjmms.sjmms_298_23. Epub 2023 Oct 6.
4
Consistent Measurement of Parasite-Specific Antigen Levels in Sera of Patients with Neurocysticercosis Using Two Different Monoclonal Antibody (mAb)-Based Enzyme-Linked Immunosorbent Assays.使用两种基于单克隆抗体(mAb)的不同酶联免疫吸附测定法对神经囊尾蚴病患者血清中寄生虫特异性抗原水平进行一致性测量。
Pathogens. 2023 Apr 6;12(4):566. doi: 10.3390/pathogens12040566.
5
Assessing the burden of Taenia solium cysticercosis in Burundi, 2020.评估 2020 年布隆迪猪带绦虫囊尾蚴病负担。
BMC Infect Dis. 2022 Nov 14;22(1):851. doi: 10.1186/s12879-022-07849-7.
6
Catalytic hairpin DNA assembly-based chemiluminescent assay for the detection of short SARS-CoV-2 target cDNA.基于催化发夹 DNA 组装的化学发光法检测短 SARS-CoV-2 靶 cDNA。
Talanta. 2021 Oct 1;233:122505. doi: 10.1016/j.talanta.2021.122505. Epub 2021 May 16.
7
Evidence for Transmission of Taeniasis/Cysticercosis in a Rural Area of Northern Rwanda.卢旺达北部农村地区猪带绦虫病/囊尾蚴病传播的证据
Front Vet Sci. 2021 Apr 20;8:645076. doi: 10.3389/fvets.2021.645076. eCollection 2021.
8
Lingual Cysticercosis: A Case Series with Review of Literature.舌部囊尾蚴病:病例系列并文献复习
Indian J Otolaryngol Head Neck Surg. 2021 Mar;73(1):116-119. doi: 10.1007/s12070-019-01763-2. Epub 2019 Nov 15.
9
Population Screening for Urine Antigens to Detect Asymptomatic Subarachnoid Neurocysticercosis: A Pilot Study in Northern Peru.秘鲁北部无症状性脑囊虫病尿液抗原的人群筛查:一项初步研究。
Am J Trop Med Hyg. 2020 Sep;103(3):1125-1128. doi: 10.4269/ajtmh.20-0196.
10
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).神经囊尾蚴病的诊断与治疗:美国传染病学会(IDSA)和美国热带医学与卫生学会(ASTMH)2017年临床实践指南。
Am J Trop Med Hyg. 2018 Apr;98(4):945-966. doi: 10.4269/ajtmh.18-88751.

本文引用的文献

1
Controversies in the management of cysticercosis.囊尾蚴病治疗中的争议
Emerg Infect Dis. 1997 Jul-Sep;3(3):403-5. doi: 10.3201/eid0303.970324.
2
Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru.抗寄生虫治疗后神经囊尾蚴病患者的血清学演变。秘鲁囊尾蚴病工作组。
J Infect Dis. 1997 Feb;175(2):486-9. doi: 10.1093/infdis/175.2.486.
3
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.
Neurology. 1997 May;48(5):1421-7. doi: 10.1212/wnl.48.5.1421.
4
Neurocysticercosis: a major cause of neurological disease worldwide.神经囊尾蚴病:全球神经系统疾病的主要病因。
Clin Infect Dis. 1997 Feb;24(2):101-13; quiz 114-5. doi: 10.1093/clinids/24.2.101.
5
Immunotherapy for porcine cysticercosis: implications for prevention of human disease. Cysticercosis Working Group in Peru.猪囊尾蚴病的免疫疗法:对预防人类疾病的意义。秘鲁囊尾蚴病工作组。
Am J Trop Med Hyg. 1997 Jan;56(1):33-7. doi: 10.4269/ajtmh.1997.56.33.
6
Discrepancies between cerebral computed tomography and western blot in the diagnosis of neurocysticercosis. The Cysticercosis Working Group in Peru (Clinical Studies Coordination Board).
Am J Trop Med Hyg. 1994 Feb;50(2):152-7. doi: 10.4269/ajtmh.1994.50.152.
7
Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League Against Epilepsy.
Epilepsia. 1994 Jan-Feb;35(1):89-93.
8
Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG).囊尾蚴病是秘鲁癫痫的主要病因。秘鲁囊尾蚴病工作组(CWG)。
Lancet. 1993 Jan 23;341(8839):197-200. doi: 10.1016/0140-6736(93)90064-n.
9
Recent advances in the diagnosis and treatment of cerebral cysticercosis.
N Engl J Med. 1984 Dec 6;311(23):1492-6. doi: 10.1056/NEJM198412063112307.
10
Immunochemical detection of antigens of larval Taenia solium and anti-larval antibodies in the cerebrospinal fluid of patients with neurocysticercosis.
J Neurol Sci. 1985 Nov;71(1):39-48. doi: 10.1016/0022-510x(85)90035-8.